Global Prostate Cancer Devices Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Device Type;

Radiation Treatment Device, Surgical Treatment Devices, and Ablation Treatment Devices.

By End-use;

Hospitals, Specialty Clinics, and Ambulatory Surgical Centers.

By Application;

Brachytherapy, Radical Prostatectomy, Cryotherapy and HIFU.

By Geography;

North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2021 - 2031).
Report ID: Rn118814956 Published Date: January, 2025 Updated Date: February, 2025

Introduction

Global Prostate Cancer Devices Market (USD Million), 2021 - 2031

In the year 2024, the Global Prostate Cancer Devices Market was valued at USD 4,534.53 million. The size of this market is expected to increase to USD 10,226.62 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 12.3%.

The global prostate cancer devices market encompasses a wide range of diagnostic and treatment devices used in the management of prostate cancer, one of the most prevalent cancers affecting men worldwide. Diagnostic devices include imaging modalities such as magnetic resonance imaging (MRI), computed tomography (CT), and positron emission tomography (PET) scans, which are used for early detection, staging, and monitoring of prostate cancer progression. Additionally, biopsy devices, including transrectal ultrasound (TRUS)-guided biopsy systems and MRI fusion biopsy systems, play a critical role in obtaining tissue samples for histological analysis and determining the aggressiveness of the cancer.

In terms of treatment devices, options vary depending on the stage and severity of the prostate cancer. Surgical devices such as robotic-assisted surgical systems, laparoscopic instruments, and traditional surgical tools are used in procedures like radical prostatectomy, which involves the removal of the prostate gland. Radiation therapy devices, including external beam radiation therapy (EBRT) systems and brachytherapy implants, deliver targeted radiation to cancerous prostate tissue while minimizing damage to surrounding healthy tissue. Additionally, advanced therapies such as high-intensity focused ultrasound (HIFU) and cryotherapy utilize thermal or freezing techniques to destroy cancer cells in the prostate, offering minimally invasive alternatives to surgery and radiation for select patients.

The global prostate cancer devices market is driven by several factors, including the increasing incidence and prevalence of prostate cancer, rising awareness and screening efforts, and technological advancements in diagnostic and treatment modalities. However, challenges such as regulatory hurdles, reimbursement issues, and the high cost of advanced devices may hinder market growth. Nevertheless, opportunities exist for innovation in device development, expansion into emerging markets, and the integration of artificial intelligence and robotics to enhance the accuracy and effectiveness of prostate cancer diagnosis and treatment, ultimately improving patient outcomes and driving further growth in the global market.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Device Type
    2. Market Snapshot, By End-use
    3. Market Snapshot, By Application
    4. Market Snapshot, By Region
  4. Global Prostate Cancer Devices Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Increasing Incidence of Prostate Cancer
        2. Technological Advancements in Diagnosis and Treatment
        3. Rising Awareness and Screening Efforts
      2. Restraints
        1. Regulatory Hurdles and Reimbursement Challenges
        2. High Cost of Advanced Devices
        3. Side Effects and Risks Associated with Treatment
      3. Opportunities
        1. Innovation in Device Development
        2. Expansion into Emerging Markets
        3. Integration of Artificial Intelligence and Robotics
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Global Prostate Cancer Devices Market, By Device Type, 2021 - 2031 (USD Million)
      1. Radiation Treatment Device
      2. Surgical Treatment Devices
      3. Ablation Treatment Devices
    2. Global Prostate Cancer Devices Market, By End-use, 2021 - 2031 (USD Million)
      1. Hospitals
      2. Specialty Clinics
      3. Ambulatory Surgical Centers
    3. Global Prostate Cancer Devices Market, By Application, 2021 - 2031 (USD Million)
      1. Brachytherapy
      2. Radical Prostatectomy
      3. Cryotherapy
      4. HIFU
    4. Global Prostate Cancer Devices Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Medtronic plc
      2. Intuitive Surgical, Inc.
      3. Accuray Incorporated
      4. Elekta AB
      5. Varian Medical Systems, Inc.
      6. Boston Scientific Corporation
      7. Siemens Healthineers AG
      8. Focal Healthcare Inc.
      9. Endocare, Inc.
      10. SonaCare Medical LLC
  7. Analyst Views
  8. Future Outlook of the Market